We are live on
!
Find out more
EPIM
Echo Point Investment Management Portfolio holdings
AUM
$26.1M
This Fund
S&P 500
This Quarter
Est. Return
-1.75%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$28M
AUM Growth
–
Cap. Flow
+$28.2M
Cap. Flow
% of AUM
100.6%
Top 10 Holdings %
Top 10 Hldgs %
99.93%
Holding
22
New
22
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceuticals
TEVA
|
+$20.5M |
| 2 |
iShares MSCI Taiwan ETF
EWT
|
+$6.34M |
| 3 |
Itaú Unibanco
ITUB
|
+$1.26M |
| 4 |
HSBC
HSBC
|
+$3.27K |
| 5 |
Prudential
PUK
|
+$3.02K |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 73.8% |
| 2 | Financials | 3.94% |
| 3 | Materials | 0.02% |
| 4 | Energy | 0.01% |
| 5 | Consumer Discretionary | 0.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Teva Pharmaceuticals
TEVA
$40.8B
| $20.7M | 73.79% |
+527,204
| New | +$20.5M |
|
|
2
iShares MSCI Taiwan ETF
EWT
$9.86B
| $6.21M | 22.17% |
+233,443
| New | +$6.34M |
|
|
3
Itaú Unibanco
ITUB
$93.2B
| $1.09M | 3.9% |
+231,987
| New | +$1.26M |
|
4
Barclays
BCS
$92.7B
| $3K | 0.01% |
+188
| New | +$2.97K |
|
|
5
HSBC
HSBC
$365B
| $3K | 0.01% |
+70
| New | +$3.27K |
|
6
ORIX
IX
$44B
| $3K | 0.01% |
+190
| New | +$2.68K |
|
|
7
Prudential
PUK
$37.6B
| $3K | 0.01% |
+92
| New | +$3.02K |
|
8
BHP
BHP
$215B
| $2K | 0.01% |
+39
| New | +$2.16K |
|
9
British American Tobacco
BTI
$131B
| $2K | 0.01% |
+32
| New | +$1.76K |
|
10
Gildan
GIL
$10.3B
| $2K | 0.01% |
+78
| New | +$1.58K |
|
|
NVO
11
Novo Nordisk
NVO
$208B
| $2K | 0.01% |
+110
| New | +$1.83K |
|
12
Toyota
TM
$224B
| $2K | 0.01% |
+18
| New | +$2.1K |
|
13
Tenaris
TS
$28.9B
| $2K | 0.01% |
+43
| New | +$1.8K |
|
|
SYT
14
DELISTED
Syngenta Ag
SYT
| $2K | 0.01% |
+30
| New | +$2.43K |
|
|
POT
15
DELISTED
Potash Corp Of Saskatchewan
POT
| $2K | 0.01% |
+42
| New | +$1.72K |
|
|
NJ
16
DELISTED
NIDEC CP (NIHON KABUSHIKI KAISHA)1 ADS REPTG .25 SH COM STK
NJ
| $2K | 0.01% |
+244
| New | +$1.99K |
|
|
SI
17
DELISTED
SIEMENS AKTIENGESELLSCHAFT ADS
SI
| $2K | 0.01% |
+22
| New | +$2.31K |
|
18
Cameco
CCJ
$37.6B
| $1K | ﹤0.01% |
+65
| New | +$1.32K |
|
19
ENI
E
$80.5B
| $1K | ﹤0.01% |
+36
| New | +$1.65K |
|
20
iShares Global Industrials ETF
EXI
$1.42B
| $1K | ﹤0.01% |
+23
| New | +$1.39K |
|
21
iShares Global Healthcare ETF
IXJ
$4.07B
| $1K | ﹤0.01% |
+38
| New | +$1.45K |
|
22
Sasol
SSL
$7.5B
| $1K | ﹤0.01% |
+26
| New | +$1.13K |
|
Similar funds
WCM
WI
VC
PGAM
RACM
PA
EM
JNI
Echo Point Investment Management's Q2 2013 Portfolio in Review
Q2 2013 is the first quarter with a 13F filing on record for Echo Point Investment Management, which disclosed 22 positions worth $28M. Its ten largest holdings account for 100% of the portfolio.
Its largest position is Teva Pharmaceuticals: 527,204 shares worth $20.7M.
By sector, the portfolio is most concentrated in Healthcare at 74% of assets, followed by Financials and Materials.
- Echo Point Investment Management's largest Q2 2013 buy was Teva Pharmaceuticals: 527,204 shares worth $20.7M.
- Echo Point Investment Management's ten largest holdings make up 100% of its $28M portfolio in Q2 2013.
- Echo Point Investment Management disclosed 22 positions in Q2 2013, its first 13F filing on record.
Based on Echo Point Investment Management's 13F filing for Q2 2013, filed 8 Aug 2013.